Want to join the conversation?
$JEC 3Q15 PR: Expects to see much of the benefit of FY15 restructuring in FY16, although some benefits are being realized in FY15, as indicated by lower G&A figures during 3Q15. Given YTD, raised full-year EPS guidance to a range of $3.11-3.31.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?